Unnamed: 0,title,date,stock,sentiment
35911.0,"Oppenheimer Maintains Outperform on Aerie Pharmaceuticals, Raises Price Target to $24",2020-06-01 11:38:00-04:00,AERI,neutral
35912.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,AERI,negative
35913.0,Shares of several healthcare companies are trading higher after US unemployment figures came in below consensus estimates. Equities have been strong this week amid a rebound in oil prices and some US states easing lockdown restrictions.,2020-05-08 10:56:00-04:00,AERI,positive
35914.0,"Mizuho Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $29",2020-05-07 11:35:00-04:00,AERI,negative
35915.0,"SunTrust Robinson Humphrey Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $22",2020-05-07 11:24:00-04:00,AERI,negative
35916.0,"HC Wainwright & Co. Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $31",2020-05-07 07:21:00-04:00,AERI,negative
35917.0,"Aerie Pharmaceuticals Q1 EPS $(0.840) Misses $(0.770) Estimate, Sales $20.341M Beat $20.060M Estimate",2020-05-06 16:05:00-04:00,AERI,negative
35918.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,AERI,positive
35919.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,AERI,neutral
35920.0,"Needham Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $38",2020-04-30 08:39:00-04:00,AERI,negative
35921.0,"CORRECTION: Mizuho Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $34; Initial Headline Had Incorrect Ticker And Company Name",2020-04-13 10:45:00-04:00,AERI,negative
35922.0,"Mizuho Maintains Outperform on Aerie Pharmaceuticals, Lowers Price Target to $26",2020-04-13 09:04:00-04:00,AERI,negative
35923.0,Aerie Pharmaceuticals shares are trading lower after the company provided a 2020 company and guidance update in response to the coronavirus.,2020-04-09 16:08:00-04:00,AERI,neutral
35924.0,Aerie Pharma Withdraws FY20 Guidance,2020-04-09 16:02:00-04:00,AERI,neutral
35925.0,"Aerie Pharma Reports Q1 Volume Up For Rhopressa, Rocklatan; Co. Has Seen No Disruptions In Supply Chain",2020-04-09 16:01:00-04:00,AERI,negative
35926.0,"Stifel Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $40",2020-04-01 10:58:00-04:00,AERI,negative
35927.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,AERI,negative
35928.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,AERI,negative
35929.0,"B of A Securities Maintains Neutral on Aerie Pharmaceuticals, Lowers Price Target to $17",2020-03-23 08:45:00-04:00,AERI,positive
35930.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,AERI,positive
35931.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,AERI,negative
35932.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,AERI,negative
35933.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,AERI,negative
35934.0,Stocks That Hit 52-Week Lows On Friday,2020-03-06 11:22:00-05:00,AERI,negative
35935.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,AERI,positive
35936.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,AERI,negative
35937.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,AERI,neutral
35938.0,94 Biggest Movers From Friday,2020-02-24 04:53:00-05:00,AERI,neutral
35939.0,68 Stocks Moving In Friday's Mid-Day Session,2020-02-21 12:29:00-05:00,AERI,neutral
35940.0,Aerie Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 sales results.,2020-02-21 08:33:00-05:00,AERI,positive
35941.0,"The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion",2020-02-21 07:46:00-05:00,AERI,negative
35942.0,"H.C. Wainwright Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $37",2020-02-21 07:20:00-05:00,AERI,negative
35943.0,33 Stocks Moving in Friday's Pre-Market Session,2020-02-21 07:15:00-05:00,AERI,neutral
35944.0,17 Stocks Moving In Thursday's After-Hours Session,2020-02-20 17:33:00-05:00,AERI,neutral
35945.0,Aerie Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 sales results.,2020-02-20 16:06:00-05:00,AERI,positive
35946.0,Aerie Sees FY20 Net Sales $100M-$110M,2020-02-20 16:02:00-05:00,AERI,neutral
35947.0,"Aerie Pharmaceuticals Q4 EPS $(0.96) Misses $(0.77) Estimate, Sales $24.7M Beat $19.46M Estimate",2020-02-20 16:01:00-05:00,AERI,negative
35948.0,Some Market Stats In 5 Minutes,2020-02-20 10:50:00-05:00,AERI,neutral
35949.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,AERI,negative
35950.0,"Aerie Pharmaceuticals Announces FDA Approval Of Its Athlone, Ireland Facility For Production Of Rocklatan 0.02%/0.005%",2020-01-21 06:30:00-05:00,AERI,positive
35951.0,"The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe",2020-01-02 08:46:00-05:00,AERI,negative
35952.0,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,2020-01-02 06:36:00-05:00,AERI,neutral
35953.0,Aerie Pharmaceuticals Announces Acceptance For Review Of Roclanda 0.02%/0.005% Marketing Authorisation Application In Europe,2020-01-02 06:30:00-05:00,AERI,positive
35954.0,Aerie Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-12-19 11:52:00-05:00,AERI,positive
35955.0,Aerie Pharmaceuticals Submits Marketing Authorisation Application For Roclanda 0.02%/0.005% In Europe,2019-12-03 06:16:00-05:00,AERI,neutral
35956.0,Aerie Pharmaceuticals Option Alert: Jan 17 $20 Calls Sweep (2) near the Ask: 4513 @ $1.601 vs 17 OI; Ref=$18.65,2019-11-26 11:49:00-05:00,AERI,positive
35957.0,"The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate",2019-11-22 08:18:00-05:00,AERI,positive
35958.0,Stocks That Hit 52-Week Lows On Thursday,2019-11-21 11:09:00-05:00,AERI,negative
35959.0,Aerie Pharma Reports Received European Commission Approval For Rohkiinsa,2019-11-21 06:30:00-05:00,AERI,positive
35960.0,Aerie Pharma to Acquire Avizorex Pharma for $10M Cash to Advance its Dry Eye Program,2019-11-18 06:31:00-05:00,AERI,neutral
35961.0,94 Biggest Movers From Yesterday,2019-11-08 06:01:00-05:00,AERI,neutral
35962.0,75 Stocks Moving In Thursday's Mid-Day Session,2019-11-07 12:19:00-05:00,AERI,neutral
35963.0,"Piper Jaffray Maintains Overweight on Aerie Pharmaceuticals, Lowers Price Target to $48",2019-11-07 12:04:00-05:00,AERI,negative
35964.0,"Stifel Nicolaus Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $45",2019-11-07 10:40:00-05:00,AERI,negative
35965.0,Aerie Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 EPS results.,2019-11-07 08:40:00-05:00,AERI,neutral
35966.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,AERI,negative
35967.0,"Cantor Fitzgerald Maintains Overweight on Aerie Pharmaceuticals, Lowers Price Target to $30",2019-11-07 06:54:00-05:00,AERI,negative
35968.0,"Aerie Pharmaceuticals Q3 EPS $(0.86) Misses $(0.8) Estimate, Sales $18.544M Beat $17.74M Estimate",2019-11-06 16:56:00-05:00,AERI,negative
35969.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,AERI,positive
35970.0,Aerie Pharmaceuticals Announces Topline Results For Netarsudil Ophthalmic Solution In Phase 2 Study Conducted In Japan,2019-11-05 06:40:00-05:00,AERI,positive
35971.0,Aerie Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.,2019-11-01 13:17:00-04:00,AERI,positive
35972.0,Mid-Morning Market Update: Gold Trades Higher; Amazon Shares Tumble,2019-10-25 10:14:00-04:00,AERI,positive
35973.0,17 Stocks Moving in Friday's Pre-Market Session,2019-10-25 08:44:00-04:00,AERI,neutral
35974.0,Aerie Pharma Reports Completion Of Enrollment In Phase 2 Trial Of AR-1105 In Patients With Macular Edema,2019-10-24 07:41:00-04:00,AERI,neutral
35975.0,Aerie Pharmaceuticals shares are trading higher on seemingly no company-specific news.,2019-10-22 12:50:00-04:00,AERI,neutral
35976.0,58 Biggest Movers From Friday,2019-10-14 03:51:00-04:00,AERI,neutral
35977.0,38 Stocks Moving In Friday's Mid-Day Session,2019-10-11 12:37:00-04:00,AERI,neutral
35978.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,AERI,positive
35979.0,"The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout",2019-10-11 08:14:00-04:00,AERI,positive
35980.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-10 11:08:00-04:00,AERI,negative
35981.0,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO",2019-10-10 07:31:00-04:00,AERI,neutral
35982.0,Aerie Pharmaceuticals shares are trading lower despite no company-specific news. Shares have been selling off since spiking on Friday following positive CHMP opinion for Rhokiinsa in the EU.,2019-09-26 11:41:00-04:00,AERI,positive
35983.0,Aerie Pharmaceuticals shares are trading lower as traders potentially took profits after the stock increased roughly 12% since last Wednesday.,2019-09-24 14:34:00-04:00,AERI,positive
35984.0,Aerie Pharmaceuticals Receives Positive CHMP Opinion For Rhokiinsa In The European Union,2019-09-20 06:31:00-04:00,AERI,positive
35985.0,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO",2019-09-19 07:39:00-04:00,AERI,neutral
35986.0,Aerie Pharmaceuticals Submits Prior Approval Supplement To FDA To Allow Production Of Rocklatan 0.02%/0.005% In Athlone Ireland Facility,2019-09-19 06:31:00-04:00,AERI,positive
35987.0,"The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug",2019-09-05 08:12:00-04:00,AERI,neutral
35988.0,60 Biggest Movers From Yesterday,2019-09-05 05:20:00-04:00,AERI,neutral
35989.0,46 Stocks Moving In Wednesday's Mid-Day Session,2019-09-04 12:27:00-04:00,AERI,neutral
35990.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-04 11:39:00-04:00,AERI,negative
35991.0,"The Daily Biotech Pulse: Puma Leaps, Aerie Borrows, Hepion Back In Nasdaq's Good Books",2019-09-04 07:08:00-04:00,AERI,positive
35992.0,Aerie Pharmaceuticals Initiates First-In-Human Clinical Trial Of AR-13503 Sustained Release Intravitreal Implant In Patients With Neovascular Age-Related Macular Degeneration And Diabetic Macular Edema,2019-08-20 06:31:00-04:00,AERI,neutral
35993.0,Aerie Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 EPS results.,2019-08-08 11:46:00-04:00,AERI,positive
35994.0,"JMP Securities Reiterates Market Outperform on Aerie Pharmaceuticals, Lowers Price Target to $52",2019-08-08 08:03:00-04:00,AERI,positive
35995.0,"Cantor Fitzgerald Reiterates Overweight on Aerie Pharmaceuticals, Lowers Price Target to $62",2019-08-08 07:58:00-04:00,AERI,negative
35996.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,AERI,negative
35997.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,AERI,neutral
35998.0,Stocks That Set New 52-Week Lows Friday Morning,2019-08-02 10:46:00-04:00,AERI,negative
35999.0,40 Healthcare Stocks Moving In Friday's After-Market Session,2019-07-29 04:25:00-04:00,AERI,neutral
36000.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,AERI,neutral
36001.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,AERI,neutral
36002.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,AERI,negative
36003.0,'Aerie Pharmaceuticals: Guidance Is Unachievable After Failed Drug Launches; 70%+ Downside' -Seeking Alpha Blog Post From Mako Research,2019-07-15 09:32:00-04:00,AERI,negative
36004.0,"The Daily Biotech Pulse: Roche Presents Positive Hemlibra Data, Amgen's Tender Offer For Nuevolution Complete, Genmab Offering",2019-07-09 07:11:00-04:00,AERI,positive
36005.0,Aerie Pharmaceuticals Completes Enrollment Of Netarsudil Ophthalmic Solution Phase 2 Clinical Trial In Japan Months Ahead Of Schedule,2019-07-09 06:31:00-04:00,AERI,positive
36006.0,"The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief",2019-07-03 07:31:00-04:00,AERI,negative
36007.0,"The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug",2019-07-02 07:29:00-04:00,AERI,positive
36008.0,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",2019-06-27 07:26:00-04:00,AERI,negative
36009.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,AERI,neutral
36010.0,Shares of several companies in the biotech space are trading higher after Pfizer announced it will acquire Array BioPharma.,2019-06-17 10:10:00-04:00,AERI,positive
36011.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-06-12 08:20:00-04:00,AERI,neutral
36012.0,"Raymond James Downgrades Ocular Therapeutix, Remains Bullish On Pipeline",2019-05-21 13:00:00-04:00,AERI,neutral
36013.0,"Canaccord Genuity Maintains Buy on Aerie Pharmaceuticals, Inc. - Common Stock, Lowers Price Target to $56",2019-05-10 08:24:00-04:00,AERI,negative
36014.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,AERI,negative
36015.0,Aerie Pharmaceuticals Reiterates FY19 Revenue Guidance Of $110M-$120M Vs. $113.02M Estimate,2019-05-07 16:34:00-04:00,AERI,neutral
36016.0,"Aerie Pharmaceuticals Q1 EPS $(0.78) Beats $(0.89) Estimate, Sales $10.852M Miss $14.75M Estimate",2019-05-07 16:31:00-04:00,AERI,negative
36017.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,AERI,neutral
36018.0,Aerie Pharmaceuticals Announces US Launch Of Rocklatan; Also Announces Increase In Rhopressa Medicare Part D Coverage,2019-05-01 07:22:00-04:00,AERI,positive
36019.0,Aerie Pharmaceuticals Announces Acceptance Of Its Investigational New Drug Application For AR-13503 Sustained Release Implant,2019-04-25 06:44:00-04:00,AERI,positive
36020.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-18 10:51:00-04:00,AERI,negative
36021.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,AERI,negative
36022.0,Aerie Pharmaceuticals To Present At The 18th Annual Needham Healthcare Conference,2019-04-02 07:31:00-04:00,AERI,neutral
36023.0,"Aerie Pharma shares trading higher, rebounding from below $45 level on Thursday. Not seeing news to justify the rebound.",2019-03-29 14:54:00-04:00,AERI,positive
36024.0,"Aerie Pharmaceuticals shares are trading higher after the company commenced patient dosing in its Phase 2 trial for Netarsudil ophthalmic solution. Additionally, Piper Jaffray initiated coverage on the stock with an Overweight rating and $80 price target.",2019-03-21 09:36:00-04:00,AERI,positive
36025.0,"Benzinga's Top Upgrades, Downgrades For March 21, 2019",2019-03-21 09:19:00-04:00,AERI,positive
36026.0,"PiperJaffray Initiates Coverage On Aerie Pharmaceuticals with Overweight Rating, Announces $80 Price Target",2019-03-21 06:53:00-04:00,AERI,negative
36027.0,Aerie Pharma Reports Commencement Of Patient Dosing In Phase 2 Trial For Netarsudil Ophthalmic Solution,2019-03-21 06:30:00-04:00,AERI,positive
36028.0,Aerie Pharmaceuticals Initiates Phase 2 Clinical Trial of AR-1105 in Patients with Macular Edema Associated with Retinal Vein Occlusion,2019-03-18 06:31:00-04:00,AERI,neutral
36029.0,68 Biggest Movers From Yesterday,2019-03-14 05:22:00-04:00,AERI,neutral
36030.0,48 Stocks Moving In Wednesday's Mid-Day Session,2019-03-13 12:41:00-04:00,AERI,neutral
36031.0,"Aerie Pharmaceuticals shares are trading higher after the company announced it received FDA approval on Rocklatan, its ophthalmic eye drop solution.",2019-03-13 09:28:00-04:00,AERI,positive
36032.0,40 Stocks Moving In Wednesday's Pre-Market Session,2019-03-13 08:10:00-04:00,AERI,neutral
36033.0,Aerie Pharmaceuticals Late Tuesday Announced FDA Approval Of Rocklatan For Reduction of Intraocular Pressure In Patients With Open-Angle Glaucoma Or Ocular Hypertension,2019-03-13 07:40:00-04:00,AERI,positive
36034.0,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",2019-03-13 07:27:00-04:00,AERI,negative
36035.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,AERI,neutral
36036.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,AERI,neutral
36037.0,72 Biggest Movers From Yesterday,2019-02-27 04:55:00-05:00,AERI,neutral
36038.0,54 Stocks Moving In Tuesday's Mid-Day Session,2019-02-26 12:18:00-05:00,AERI,neutral
36039.0,Aerie Pharmaceuticals shares are trading higher after the company beat Q4 sales estimates.,2019-02-26 11:31:00-05:00,AERI,positive
36040.0,"Aerie Pharmaceuticals Q4 EPS $(0.92) Misses $(0.86) Estimate, Sales $14.456M Beat $13.22M Estimate",2019-02-25 16:25:00-05:00,AERI,negative
36041.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,AERI,neutral
36042.0,Aerie Pharmaceuticals Announces FDA Acceptance Of Its Investigational New Drug Application For AR-1105,2019-01-17 06:36:00-05:00,AERI,positive
36043.0,UPDATE: Aerie Says Netarsudil Solution 'lowered IOP in mean diurnal IOP by a range of 5.0 to 5.3 mmHg for subjects with an average baseline IOP of 18.3 mmHg',2019-01-04 06:35:00-05:00,AERI,positive
36044.0,Aerie Pharma Reports Topline Results From Phase 2 Study Of Netarsudil In Japan,2019-01-04 06:34:00-05:00,AERI,neutral
36045.0,Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved,2018-12-18 08:55:00-05:00,AERI,positive
36046.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,AERI,positive
36047.0,"Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018",2018-12-17 11:48:00-05:00,AERI,negative
36048.0,31 Stocks Moving In Monday's Pre-Market Session,2018-12-10 08:16:00-05:00,AERI,neutral
36049.0,"Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018",2018-11-28 11:54:00-05:00,AERI,negative
36050.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018",2018-11-27 11:26:00-05:00,AERI,negative
36051.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018",2018-11-21 08:50:00-05:00,AERI,negative
36052.0,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",2018-11-15 08:10:00-05:00,AERI,positive
36053.0,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut",2018-11-14 08:17:00-05:00,AERI,neutral
36054.0,"Benzinga's Top Upgrades, Downgrades For November 13, 2018",2018-11-13 09:18:00-05:00,AERI,positive
36055.0,"Oppenheimer Initiates Coverage On Aerie Pharmaceuticals with Outperform Rating, Announces $64 Price Target",2018-11-13 08:53:00-05:00,AERI,neutral
36056.0,"The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut",2018-11-13 07:54:00-05:00,AERI,negative
36057.0,"Aerie Pharmaceuticals Q3 EPS $(0.71), Same YoY, Sales $7.302M",2018-11-06 16:07:00-05:00,AERI,neutral
36058.0,"The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering",2018-11-06 07:04:00-05:00,AERI,positive
36059.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,AERI,neutral
36060.0,"Aerie Pharmaceuticals, Inc. Announces European Medicines Agency Has Accepted For Review The Marketing Authorisation Application For Drug Application For Rhokiinsa",2018-10-09 06:31:00-04:00,AERI,positive
36061.0,Aerie Pharma Names Former Incyte CFO David Gryska to its Board,2018-09-12 16:03:00-04:00,AERI,neutral
36062.0,Aerie Pharmaceuticals Names Robert Finan Director of Finance,2018-09-11 16:02:00-04:00,AERI,neutral
36063.0,"Stifel Nicolaus Maintains Buy on Aerie Pharmaceuticals, Raises Price Target to $87",2018-09-11 06:56:00-04:00,AERI,neutral
36064.0,Aerie Pharmaceuticals Option Alert: Nov 16 $80 Calls at the Ask: 750 @ $0.6 vs 5 OI; Ref=$61.225,2018-08-31 10:17:00-04:00,AERI,positive
36065.0,"Aerie Pharma Filing Shows Registration For 329K Share Common Stock Offering Via Selling Holders, Deerfield",2018-08-22 17:08:00-04:00,AERI,positive
36066.0,UPDATE: Aerie Pharmaceuticals Says Rhopressa Produced A Statistically Significant Increase In Trabecular Outflow Facility Of ~35% Over Baseline,2018-08-15 06:34:00-04:00,AERI,positive
36067.0,Aerie Pharmaceuticals Reports Topline Result From Rhopressa Mechanism Of Action Study,2018-08-15 06:31:00-04:00,AERI,neutral
36068.0,Aerie Pharma Reaffirms FY18 Rhopressa Sales $20M-$30M With Total Cash Burn $200M-$210M,2018-08-08 16:40:00-04:00,AERI,neutral
36069.0,"Aerie Pharmaceuticals Q2 EPS $(1.40) Misses $(0.98) Estimate, Sales $2.423M Beat $520K Estimate",2018-08-08 16:40:00-04:00,AERI,negative
36070.0,"Aerie Pharmaceuticals, DSM Biomedical Expand Partnership Agreement Focused on Novel Drug Delivery Technology in Ophthalmology; Aerie Paid DSM $6M On Expanded Agreement, With An Additional $9M Payable To DSM Through 2020",2018-08-01 06:43:00-04:00,AERI,positive
36071.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,AERI,neutral
36072.0,"Aerie Pharmaceuticals Announces Early Notification of FDA Acceptance of NDA Submission for Roclatan with PDUFA Date Set for March 14, 2019",2018-07-23 06:32:00-04:00,AERI,positive
36073.0,Stocks Which Set New 52-Week High Yesterday,2018-07-20 09:05:00-04:00,AERI,neutral
36074.0,"Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering",2018-07-13 08:34:00-04:00,AERI,neutral
36075.0,"Top 20 Stocks With Highest Short Interest For Week Starting Jul. 2, 2018",2018-07-05 16:55:00-04:00,AERI,positive
36076.0,"Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap",2018-06-22 08:51:00-04:00,AERI,neutral
36077.0,"Jefferies Global Healthcare Begins Today, Presenters Include: Kadmon, Aeri Pharma, Chemed, Orthofix, Revance, Heron Therapeutics, and Dicerna Pharma",2018-06-05 08:55:00-04:00,AERI,neutral
36078.0,Benzinga Pro's 5 Stocks To Watch Today,2018-05-15 09:04:00-04:00,AERI,neutral
36079.0,Aerie Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for RoclatanTM 0.02%/0.005%,2018-05-15 06:31:00-04:00,AERI,neutral
36080.0,"Top 20 Stocks With Highest Short Interest For Week Started May 14, 2018",2018-05-14 15:55:00-04:00,AERI,positive
36081.0,Aerie Pharmaceuticals Q1 EPS $(0.83) Beats $(0.87) Estimate,2018-05-08 17:19:00-04:00,AERI,neutral
36082.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,AERI,neutral
36083.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,AERI,neutral
36084.0,"Top 20 Stocks With Highest Short Interest For Week Ended May 4, 2018",2018-05-04 15:44:00-04:00,AERI,positive
36085.0,Aerie Pharmaceuticals Announces US Launch of Rhopressa 0.02%,2018-04-30 06:41:00-04:00,AERI,neutral
36086.0,Zacks: 3 Drug Stocks To Avoid For Now,2018-03-27 11:33:00-04:00,AERI,negative
36087.0,Aerie Pharmaceuticals Reports Q4 EPS $(1.38) vs $(1.27) Est.,2018-02-28 16:02:00-05:00,AERI,neutral
36088.0,"H.C. Wainwright Assumes Aerie Pharmaceuticals at Buy, Announces price target $78.00",2018-02-16 07:06:00-05:00,AERI,neutral
36089.0,"Benzinga's Top Upgrades, Downgrades For January 26, 2018",2018-01-26 09:14:00-05:00,AERI,positive
36090.0,"Seaport Global Initiates Coverage On Aerie Pharmaceuticals with Buy Rating, Announces $78.00 Price Target",2018-01-26 08:04:00-05:00,AERI,neutral
36091.0,Aerie Pharma Shares Down 7.4% Following Pricing Of $75M Common Stock Offering,2018-01-24 11:48:00-05:00,AERI,positive
36092.0,Aerie Pharmaceuticals Announces Pricing of Public Offering of Common Stock; Price Not Mentioned in PR,2018-01-24 06:31:00-05:00,AERI,neutral
36093.0,Aerie Pharma Announces $75M Common Stock Offering,2018-01-23 16:03:00-05:00,AERI,neutral
36094.0,Aerie Pharma Announces a Controlled Equity Offering to Sell up to $75M of Stock From Time to Time,2017-12-19 06:29:00-05:00,AERI,neutral
36095.0,"Aerie Pharma Shares Open For Trade, Move Lower, Down 2.2%",2017-12-18 16:27:00-05:00,AERI,neutral
36096.0,Aerie Pharma Shares To Resume Trade At 4:25 p.m. EST,2017-12-18 16:06:00-05:00,AERI,positive
36097.0,Aerie Pharma Says it is Still on Track to File a Roclatan NDA in Q2 2018,2017-12-18 15:54:00-05:00,AERI,neutral
36098.0,Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa 0.02% for the Lowering of Elevated Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension,2017-12-18 15:52:00-05:00,AERI,neutral
36099.0,"Aerie Pharma Shares Halted, News Pending",2017-12-18 15:50:00-05:00,AERI,positive
36100.0,Aeri Pharmaceuticals Initiates Phase 2 Trial For Netarsudil Ophthalmic Solution,2017-11-16 16:01:00-05:00,AERI,positive
36101.0,"Stifel 2017 Healthcare Conference Begins Today, Presenters Include: Seres Therapeutics, Verastem, TherapeuticsMD, Aerie Pharmaceuticals, Mednax, Celgene, TransEnterix, Exelixis, Tandem Diabetes Care and Masimo",2017-11-14 09:36:00-05:00,AERI,positive
36102.0,Aeri Pharmaceuticals Reports Adj. EPS $(0.67) vs $(0.64) Est.,2017-11-08 16:27:00-05:00,AERI,neutral
36103.0,"Guggenheim Initiates Coverage On Aerie Pharmaceuticals with Buy Rating, Announces $80.00 Price Target",2017-10-24 09:15:00-04:00,AERI,neutral
36104.0,"Aerie Pharma Shares Resume Trade, Now Up 3.3%",2017-10-13 14:20:00-04:00,AERI,positive
36105.0,Aerie Pharma Shares To Resume Trade At 2:20 p.m. EDT,2017-10-13 14:05:00-04:00,AERI,positive
36106.0,"UPDATE: Aerie Pharma Says PDUFA Goal Date Is Feb. 28, 2018",2017-10-13 13:56:00-04:00,AERI,neutral
36107.0,Aerie Pharma Reports FDA Panel Voted In Favor Of Rhopressa 0.02%,2017-10-13 13:55:00-04:00,AERI,positive
36108.0,FDA AdCom Meeting Panel Votes Aerie Rhopressa Drug Efficacy Outweighs Risks,2017-10-13 12:53:00-04:00,AERI,negative
36109.0,"Aerie Releases PR Saying FDA Advisory Committee to Review New Drug Application for Rhopressa, Advisory Committee Meeting Scheduled For 8:30 a.m. ET Today",2017-10-13 07:07:00-04:00,AERI,neutral
36110.0,Aerie Pharma Shares Halted News Pending,2017-10-13 07:00:00-04:00,AERI,positive
36111.0,Aerie Pharma's FDA Briefing Docs: Good News With No Surprises; Shares Scale A Record,2017-10-11 15:00:00-04:00,AERI,positive
36112.0,Mid-Afternoon Market Update: Hudson Technologies Drops Amid Concerning Guidance; Aerie Pharmaceutical Shares Gain,2017-10-11 14:29:00-04:00,AERI,positive
36113.0,28 Stocks Moving In Wednesday's Mid-Day Session,2017-10-11 12:19:00-04:00,AERI,neutral
36114.0,Mid-Day Market Update: VOXX International Falls After Q2 Results; CASI Pharmaceuticals Shares Climb,2017-10-11 12:09:00-04:00,AERI,positive
36115.0,Mid-Morning Market Update: Markets Mostly Flat; Delta Air Lines Earnings Top Views,2017-10-11 10:12:00-04:00,AERI,positive
36116.0,Aerie Pharmaceutical Shares Up 16.7% Following Positive Prelim FDA Data On Rhopressa Earlier This Morning,2017-10-11 09:31:00-04:00,AERI,positive
36117.0,Aerie Pharmaceuticals Glaucoma Therapy Rhopressa Is Effective In Prelim FDA Review,2017-10-11 08:48:00-04:00,AERI,positive
36118.0,"The Week Ahead: New IPOs, Bank Earnings, And Some Notable FDA Actions",2017-10-09 10:31:00-04:00,AERI,neutral
36119.0,Aerie Pharmaceuticals Acquires Right to Use Print Technology from Envisa Therapeutics for $25M Initial Payment,2017-10-05 06:02:00-04:00,AERI,neutral
36120.0,"Aerie Pharma Shares Spike To Session Highs, Currently Up 0.6% Following Mention Of Notable Option Activity From Pete Najarian On CNBC's 'Fast Money: Halftime Report'",2017-10-03 13:01:00-04:00,AERI,positive
